Highly Selective Catalytic Reactions of Alkenes and Alkynes Relevant to Medicinal and Process Chemistry

与医药和工艺化学相关的烯烃和炔烃的高选择性催化反应

基本信息

  • 批准号:
    10544730
  • 负责人:
  • 金额:
    $ 38.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-01-01 至 2025-12-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract A recent critical analysis of biologically active molecules and reactions most often used for their preparation suggests that fraction of saturated carbons and presence of chiral centers correlate with success as a compound moves from discovery, through clinical trials to an approved drug. About a third of the compounds had at least one chiral center. In addition, practical aspects of manufacturing still need to be addressed to market a cost effective drug. Thus discovery of fundamentally new catalytic reactions, especially enantioselective ones, showing high turnover frequencies (i.e., substrate/ catalyst/unit time), that use readily available precursors, will have a significant impact on medicinal and process chemistry. Through an approach that relies heavily on mechanistic insights we strive to discover new enantioselective reactions of alkenes and alkynes. For example, use of low-valent chiral (L*)cobalt complexes has enabled heterodimerization between a broad range of 1,3-dienes, and, ethylene and alkyl acrylates, which are feedstock materials. The products of these reactions are synthetically valuable chiral 1,4-skipped dienes (produced in >90% yield and ee) which can be turned into pharmaceutically relevant classes of compounds. Examples cited include anti-microbial and anti-tumor and antifungal agents, GABA analogs, and metalloproteinase inhibitors. On-going mechanistic studies strongly suggest the intermediacy of a cationic {[P~P)Co(L)]+}X– species in these exceptionally selective C-C bond-forming reactions that proceed under ambient conditions. Most remarkably, we recently (2018/2019) found that the chiral cationic Co(I) complexes with custom-designed ligands catalyze enantioselective [2+2]-additions of alkynes and vinyl-X derivatives, opening, arguably, the best route to enantiopure 3-substituted cyclobutenes, potential precursors other valuable compounds. In sharp contrast to 1,3-dienes, 1,3-enynes form, initially, vinylcyclobutenes and then, in a tandem fashion, highly functionalized cyclobutanes with an all-carbon quaternary centers. Such reactions are highly efficient and uncommon. Preliminary results also indicate that chiral cationic Co(I)-complexes catalyze at least 4 other types of reactions (hydroboration, hydroacylation and hydrosilylation of prochiral 1,3-dienes, and, cyclizaion/HV of 1,6- enynes). We plan to explore how many of the combinations of reactions can be run in tandem, in attempts to exploit the full potential of the new cobalt chemistry in organic syntheis. Historically some of the reactions we work on had been carried out using precious metals. We expect, when fully devloped, cobalt (which is 100 to 200 time cheaper than Rh for example), will be able to catalyze some of these basic reactions. The interdisciplinary nature of the work proposed here provides outstanding opportunities to train future scientists at every level of their education.
项目总结/摘要 最近对生物活性分子和最常用于其 制备表明,饱和碳的分数和手性中心的存在与 一个化合物的成功是从发现,通过临床试验,到被批准的药物。大约一 三分之一的化合物具有至少一个手性中心。此外,制造业的实际方面 仍然需要解决以销售成本有效的药物。从而发现了一种全新的 催化反应,特别是对映选择性反应,显示出高的转换频率(即, 底物/催化剂/单位时间),使用容易获得前体,将对 医药和工艺化学。通过一种严重依赖于机械见解的方法 我们致力于发现烯烃和炔烃的新的对映选择性反应。例如使用 低价手性(L*)钴络合物已经使得能够在宽范围的 1,3-二烯和乙烯和丙烯酸烷基酯,它们是原料。这些产品 反应是合成上有价值的手性1,4-跳过的二烯(以>90%的产率和ee生产) 其可以转化为药学相关类别的化合物。列举的例子包括 抗微生物和抗肿瘤和抗真菌剂、GABA类似物和金属蛋白酶 抑制剂的正在进行的机械研究强烈表明,阳离子的中间性 {[P~P)Co(L)]+}X-物种在这些异常选择性的C-C键形成反应中进行, 在环境条件下。最值得注意的是,我们最近(2018/2019)发现,手性阳离子 Co(I)配合物催化炔的对映选择性[2+2]加成反应 和乙烯基-X衍生物,可以说,打开了获得对映体纯的3-取代环丁烯的最佳途径, 潜在的前体其他有价值的化合物。与1,3-二烯形成鲜明对比,1,3-烯炔形成, 首先,乙烯基环丁烯,然后,以串联方式,高度官能化的环丁烷, 全碳四元中心这种反应是非常有效和罕见的。初步 结果还表明,手性阳离子Co(I)-配合物催化至少4种其他类型的反应 (前手性1,3-二烯的硼氢化、氢酰化和硅氢化,以及1,6-二烯的环化/HV) enynes)。我们计划探索有多少种反应组合可以同时进行, 试图开发新的钴化学在有机合成中的全部潜力。历史上 我们研究的一些反应是用贵金属进行的。我们预计,当 完全开发的钴(例如比Rh便宜100到200倍)将能够 催化这些基本反应。这里提出的工作的跨学科性质 提供了良好的机会,培养未来的科学家在他们的教育的各个层次。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

T V RAJANBABU其他文献

T V RAJANBABU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('T V RAJANBABU', 18)}}的其他基金

Highly Selective Catalytic Reactions of Alkenes and Alkynes Relevant to Medicinal and Process Chemistry
与医药和工艺化学相关的烯烃和炔烃的高选择性催化反应
  • 批准号:
    10320911
  • 财政年份:
    2021
  • 资助金额:
    $ 38.4万
  • 项目类别:
Highly Selective Catalytic Reactions of Alkenes and Alkynes Relevant to Medicinal and Process Chemistry
与医药和工艺化学相关的烯烃和炔烃的高选择性催化反应
  • 批准号:
    10581995
  • 财政年份:
    2021
  • 资助金额:
    $ 38.4万
  • 项目类别:
New Alkene Chemistry for the Synthesis of Medicinally Relevant Compounds
用于合成医学相关化合物的新烯烃化学
  • 批准号:
    9297349
  • 财政年份:
    2015
  • 资助金额:
    $ 38.4万
  • 项目类别:
Development and Applications of Asymmetric Hydrovinylation of Alkenes
烯烃不对称氢乙烯基化的研究进展及应用
  • 批准号:
    7858243
  • 财政年份:
    2007
  • 资助金额:
    $ 38.4万
  • 项目类别:
Development and Applications of Asymmetric Hydrovinylation of Alkenes
烯烃不对称氢乙烯基化的研究进展及应用
  • 批准号:
    7623571
  • 财政年份:
    2007
  • 资助金额:
    $ 38.4万
  • 项目类别:
Development and Applications of Asymmetric Hydrovinylation of Alkenes
烯烃不对称氢乙烯基化的研究进展及应用
  • 批准号:
    7473969
  • 财政年份:
    2007
  • 资助金额:
    $ 38.4万
  • 项目类别:
Development and Applications of Asymmetric Hydrovinylation of Alkenes
烯烃不对称氢乙烯基化的研究进展及应用
  • 批准号:
    7320569
  • 财政年份:
    2007
  • 资助金额:
    $ 38.4万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 38.4万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.4万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 38.4万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.4万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 38.4万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.4万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 38.4万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 38.4万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 38.4万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.4万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了